General Hospital Psychiatry
Volume 30, Issue 1 , Pages 26-31 , January 2008

Trajectories of improvement for six depression-related outcomes

  • James E. Aikens, Ph.D.

      Affiliations

    • Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109-5708, USA
    • Department of Psychiatry, University of Michigan, Ann Arbor, MI 48109-5708, USA
    • Corresponding Author InformationCorresponding author. Department of Family Medicine; University of Michigan, Ann Arbor, MI 48109-5708, USA. Tel.: +1 734 998 7120x320; fax: +1 734 998 7335.
    • ,
  • Kurt Kroenke, M.D.

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202-3002, USA
    • Regenstrief Institute, Indianapolis, IN 46202-3012, USA
    • ,
  • Donald E. Nease Jr., M.D.

      Affiliations

    • Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109-5708, USA
    • ,
  • Michael S. Klinkman, M.D., M.S.

      Affiliations

    • Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109-5708, USA
    • Department of Psychiatry, University of Michigan, Ann Arbor, MI 48109-5708, USA
    • ,
  • Ananda Sen, Ph.D.

      Affiliations

    • Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109-5708, USA
    • Department of Statistics, and Center for Statistical Consultation and Research (CSCAR), University of Michigan, Ann Arbor, MI 48109-1070, USA

Received 10 August 2007 ,Accepted 11 October 2007.

References 

  1. Penninx BW, Guralnik JM, Ferrucci L, Simonsick EM, Deeg DJ, Wallace RB. Depressive symptoms and physical decline in community-dwelling older persons. JAMA. 1998;279:1720–1726
  2. Armenian HK, Pratt LA, Gallo J, Eaton WW. Psychopathology as a predictor of disability: a population-based follow-up study in Baltimore, Maryland. Am J Epidemiol. 1998;148:269–275
  3. Ormel J, VonKorff M, Oldehinkel AJ, Simon G, Tiemens BG, Üstün TB. Onset of disability in depressed and non-depressed primary care patient. Psychol Med. 1999;29:847–853
  4. Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, et al Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry. 2000;57(4):375–380
  5. Ormel J, Von Korff M, Van den Brink W, Katon W, Brilman E, Oldehinkel T. Depression, anxiety, and social disability show synchrony of change in primary care patients. Am J Public Health. 1993;83:385–390
  6. Judd LL, Akiskal HS. Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds. Pharmacopsychiatry. 2000;33:3–7
  7. Mintz J, Mintz LI, Arruda MJ, Hwang SS. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry. 1992;49:761–768
  8. Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, et al. Psychosocial disability during the long- term course of unipolar major depressive disorder. Arch Gen Psychiatry. 2000;57:375–380
  9. Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R, et al. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA. 2001;2:2947–2955
  10. Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53:924–932
  11. Simon GE, Revicki D, VonKorff M. Telephone assessment of depression severity. J Psychiatr Res. 1993;27:247–252
  12. Stewart AL, Ware JE. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham (NC): Duke University Press; 1992;
  13. Jette AM, Davies AR, Cleary PD, Calkins DR, Rubenstein LV, Fink A, et al. The Functional Status Questionnaire: reliability and validity when used in primary care. J Gen Intern Med. 1986;1:143–149
  14. Hays RD, Cunningham WE, Shapiro MF. Derivation of Physical and Mental Health Composite Indices in the HIV Outcomes Study. Santa Monica (Calif): RAND; 1996;
  15. Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64:258–266
  16. Lerner D, Amick B. Work Limitations Questionnaire. Boston (Mass): The Health Institute, New England Medical Center; 1998;
  17. Clark DO, Von Korff M, Saunders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Med Care. 1995;33:783–795
  18. George J, Vuong T, Bailey MJ, Kong DC, Marriott JL, Stewart K. Development and validation of the medication-based disease burden index. Ann Pharmacother. 2006;40:645–650
  19. O'Malley PG, Jackson JL, Santoro J, Tomkins G, Balden E, Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract. 1999;48:980–990
  20. Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom. 2000;69:205–215
  21. Jackson JL, O'Malley PG, Kroenke K. Antidepressants and cognitive-behavioral therapy for symptom syndromes. CNS Spectr. 2006;11:212–222
  22. Damush TM, Weinberger M, Perkins SM, Rao JK, Tierney WM, Qi R, et al. Randomized trial of a self-management program for primary care patients with acute low back pain: short-term effects. Arthritis Rheum. 2003;49:179–186
  23. Aikens JE, Nease DE, Nau DP, Klinkman MS, Schwenk TL. Adherence to maintenance - phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med. 2005;3:23–30
  24. Aikens JE, Kroenke K, Swindle R, Eckert GJ. Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care. Gen Hosp Psychiatry. 2005;27:229–236
  25. Range LM, Penton SR. Hope, hopelessness, and suicidality in college students. Psychol Rep. 1994;75:456–458
  26. Needles DJ, Abramson LY. Positive life events, attributional style, and hopefulness: testing a model of recovery from depression. J Abnorm Psychol. 1990;2:156–165
  27. Conner KR, Duberstein PR, Conwell Y, Seidlitz L, Caine ED. Psychological vulnerability to completed suicide: a review of empirical studies. Suic Life Threat Behav. 2001;31:367–385

☆ Conflict of interest: Drs. Aikens, Klinkman, Kroenke, Nease and Sen have received research support from Eli Lilly, Inc. Dr. Aikens has served as paid consultant to Pfizer. Dr. Klinkman has served as a paid consultant to Wyeth Pharmaceuticals. Dr. Kroenke has received honoraria from Pfizer, Eli Lilly and Wyeth.

PII: S0163-8343(07)00193-4

doi: 10.1016/j.genhosppsych.2007.10.003

General Hospital Psychiatry
Volume 30, Issue 1 , Pages 26-31 , January 2008

Article Tools

* Image Usage & Resolution